mitomycin has been researched along with losartan potassium in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.64) | 18.7374 |
| 1990's | 6 (27.27) | 18.2507 |
| 2000's | 6 (27.27) | 29.6817 |
| 2010's | 7 (31.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsieh, DP; Kado, NY; Kuzmicky, PA; Ning, HS | 1 |
| Kaku, M; Motomura, S; Nakamura, K; Okano, H | 1 |
| Li, J; Mozawa, K; Nagae, Y; Sakaba, H; Shimizu, H; Suzuki, Y; Takahashi, A | 1 |
| Ariyuki, F; Kondo, Y; Nito, S; Ono, T | 1 |
| Fukumoto, M; Ishikawa, T; Kadokura, M; Okonogi, H; Sakaba, H; Shimizu, H; Suzuki, Y | 1 |
| Casey, S; O'Brien, ME; Powles, TJ; Treleaven, J | 1 |
| Beug, H; Deiner, E; Leutz, A; Steinlein, P | 1 |
| Kurata, Y; Sawai, T; Takeshita, Y; Yajima, N | 1 |
| Kale, VP; Limaye, LS | 1 |
| Glaser, CM; Kornek, GV; Lang, S; Lavey, RS; Millesi, W; Schüll, B; Selzer, E; Watzinger, F | 1 |
| Ariyoshi, Y; Fukuoka, M; Furuse, K; Ikegami, H; Kishimoto, S; Kunikane, H; Saijo, N; Watanabe, K | 1 |
| Catalano, C; Fabbian, F; Gianesini, C | 1 |
| Buchwald, M; Carreau, M; Dick, JE; Gan, OI; Hitzler, JK; Liu, L | 1 |
| Sallah, S; Sigounas, G; Sigounas, VY | 1 |
| Beem, E; Sautina, L; Segal, MS; Shah, R; Zharikov, SI | 1 |
| Chrisafi, S; Digkas, EN; Hatzimichail, A; Lialiaris, TS; Passadaki, T; Tsalkidis, A; Vargemezis, V | 1 |
| Cartei, F; Cartei, G; Colombrino, E; Fiorica, F; Giraldi, T; Micucci, M; Plebani, M; Sanzari, MC; Zustovich, F | 1 |
| Abid, S; Achour, A; Ayed-Boussema, I; Bacha, H; Guedri, Y; Rjiba-Touati, K | 1 |
| Abid, S; Achour, A; Ayed-Boussema, I; Bacha, H; Rjiba-Touati, K; Soualeh, N | 1 |
| Abid, S; Achour, A; Ayed-Boussema, I; Bacha, H; Belarbia, A; Mokni, M; Rjiba-Touati, K | 1 |
| Abid-Essefi, S; Achour, A; Ayed-Boussema, I; Bacha, H; Guedri, Y; Rjiba-Touati, K | 1 |
| Itoh, K; Masumori, S; Mukai, D; Sakakibara, H; Shimoi, K; Yasuda, M | 1 |
2 trial(s) available for mitomycin and losartan potassium
| Article | Year |
|---|---|
Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Carcinoma, Non-Small-Cell Lung; Cisplatin; Double-Blind Method; Drug Administration Schedule; Erythropoietin; Female; Hemoglobins; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Recombinant Proteins; Treatment Outcome; Vindesine | 2001 |
Chronic anemia due to mitomycin C is drug dose-dependent, normocytic, progressive, related to erythropoietin levels and quantitatively predictable: implications for radiochemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Chemoradiotherapy; Chronic Disease; Disease Progression; Dose-Response Relationship, Drug; Erythrocytes; Erythropoietin; Female; Hematocrit; Hemoglobins; Humans; Male; Middle Aged; Mitomycin; Neoplasms; Prospective Studies | 2011 |
20 other study(ies) available for mitomycin and losartan potassium
| Article | Year |
|---|---|
Micronucleus formation in cultured fetal liver blood cells using mitomycin C.
Topics: Animals; Cells, Cultured; Dose-Response Relationship, Drug; Erythrocytes; Erythropoietin; Fetus; Kinetics; Liver; Mice; Micronucleus Tests; Mitomycin; Mutagens | 1991 |
In vitro differentiation of a human erythroid cell line (KMOE) induced by some metabolic inhibitors.
Topics: Antimetabolites; Benzidines; Cell Differentiation; Cell Line; Cytarabine; Daunorubicin; Erythrocytes; Erythropoietin; Hemoglobins; Humans; Isoelectric Focusing; Mitomycin; Mitomycins; Radioimmunoassay; Staining and Labeling | 1985 |
The micronucleus test and erythropoiesis. Effects of erythropoietin and a mutagen on the ratio of polychromatic to normochromatic erythrocytes (P/N ratio).
Topics: Animals; Bone Marrow; Chromatin; Erythrocyte Count; Erythrocytes; Erythropoiesis; Erythropoietin; Male; Mice; Micronucleus Tests; Mitomycin; Mitomycins; Mutagens | 1989 |
In vitro micronucleus method with erythropoietin-differentiated erythrocytes.
Topics: Animals; Bone Marrow Cells; Cell Differentiation; Cell Nucleus; Chromosome Aberrations; Erythrocytes; Erythropoietin; Male; Mice; Mice, Inbred C57BL; Mitomycin; Mitomycins; Mutagenicity Tests; Mutagens | 1986 |
Effects of prostaglandin E2 on the micronucleus formation in mouse bone marrow cells by various mutagens.
Topics: 2-Naphthylamine; Animals; Benzo(a)pyrene; Blood Cell Count; Bone Marrow; Bone Marrow Cells; Dimethylhydrazines; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; Erythroblasts; Erythropoiesis; Erythropoietin; Fluorouracil; Male; Mice; Mice, Inbred BALB C; Micronucleus Tests; Mitomycin; Mutagens; Time Factors; Vincristine | 1994 |
Use of erythropoietin in the management of the haemolytic uraemic syndrome induced by mitomycin C/tamoxifen.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Erythropoietin; Female; Hemolytic-Uremic Syndrome; Humans; Middle Aged; Mitomycin; Tamoxifen | 1994 |
Recombinant murine erythropoietin receptor expressed in avian erythroid progenitors mediates terminal erythroid differentiation in vitro.
Topics: Anemia; Animals; Bone Marrow Cells; Cell Differentiation; Cell Line, Transformed; Cells, Cultured; Chick Embryo; Chickens; Erythroblasts; Erythropoietin; Hematopoietic Stem Cells; Insulin; Kinetics; Mice; Mitomycin; Receptors, Erythropoietin; Recombinant Proteins; Transfection | 1994 |
Induction of micronucleated erythrocytes by recombinant human erythropoietin.
Topics: Animals; Biotransformation; Bone Marrow; Cells, Cultured; Chromosome Aberrations; Cricetinae; Cricetulus; Erythrocytes; Erythropoietin; Escherichia coli; Humans; Lung; Lymphocytes; Male; Mice; Mice, Inbred Strains; Micronuclei, Chromosome-Defective; Micronucleus Tests; Microsomes, Liver; Mitomycin; Mutagenesis; Mutagenicity Tests; Mutagens; Recombinant Proteins; Salmonella typhimurium | 1993 |
Stimulation of adult human bone marrow by factors secreted by fetal liver hematopoietic cells: in vitro evaluation using semisolid clonal assay system.
Topics: Adult; Bone Marrow Cells; Cell Count; Cell Line; Cell Survival; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Erythropoietin; Fetus; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Interleukin-3; Liver; Mitomycin; Transforming Growth Factor beta | 1999 |
Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Erythropoietin; Female; Fluorouracil; Hemoglobins; Humans; Male; Middle Aged; Mitomycin; Mouth Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Oropharyngeal Neoplasms; Preoperative Care; Recombinant Proteins; Retrospective Studies | 2001 |
Erythropoietin is beneficial in mitomycin-induced hemolytic-uremic syndrome.
Topics: Antibiotics, Antineoplastic; Colonic Neoplasms; Erythropoietin; Female; Hemolytic-Uremic Syndrome; Humans; Middle Aged; Mitomycin | 2002 |
Short-term granulocyte colony-stimulating factor and erythropoietin treatment enhances hematopoiesis and survival in the mitomycin C-conditioned Fancc(-/-) mouse model, while long-term treatment is ineffective.
Topics: Animals; Bone Marrow; Erythrocyte Count; Erythropoietin; Fanconi Anemia; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cells; Leukocyte Count; Mice; Mice, Inbred BALB C; Mice, Knockout; Mitomycin; Pancytopenia; Survival Rate | 2002 |
Erythropoietin modulates the anticancer activity of chemotherapeutic drugs in a murine lung cancer model.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Lewis Lung; Cisplatin; Cyclophosphamide; Disease Models, Animal; Drug Interactions; Erythropoietin; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mitomycin; Neoplasm Metastasis | 2004 |
Mitomycin- and calcineurin-associated HUS, endothelial dysfunction and endothelial repair: a new paradigm for the puzzle?
Topics: Adenocarcinoma; Adult; Antibiotics, Antineoplastic; Antigens, CD34; Biomarkers; Burkitt Lymphoma; Calcineurin; Endothelium, Vascular; Erythropoietin; Female; Hemolytic-Uremic Syndrome; Humans; Male; Mitomycin; Renal Dialysis; Stomach Neoplasms | 2007 |
In vitro and in vivo cytogenetic effects of recombinant human erythropoietin on the frequency of sister chromatid exchanges alone or in combination with mitomycin C.
Topics: Adolescent; Adult; Animals; Cells, Cultured; Cytogenetic Analysis; Drug Combinations; Erythropoietin; Humans; Leukemia P388; Lymphocytes; Mice; Mitomycin; Recombinant Proteins; Sister Chromatid Exchange; Young Adult | 2010 |
Role of recombinant human erythropoietin in mitomycin C-induced genotoxicity: analysis of DNA fragmentation, chromosome aberrations and micronuclei in rat bone-marrow cells.
Topics: Alkylating Agents; Animals; Antimutagenic Agents; Bone Marrow Cells; Chromosome Aberrations; DNA Fragmentation; Drug Administration Schedule; Drug Evaluation, Preclinical; Epoetin Alfa; Erythropoietin; Male; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mitomycin; Random Allocation; Rats; Rats, Wistar; Recombinant Proteins | 2013 |
Antioxidant and antigenotoxic role of recombinant human erythropoeitin against alkylating agents: cisplatin and mitomycin C in cultured Vero cells.
Topics: Acute Kidney Injury; Alkylating Agents; Animals; Antioxidants; Cells, Cultured; Chlorocebus aethiops; Cisplatin; DNA Damage; Erythropoietin; Glutathione; Humans; In Vitro Techniques; Kidney; Malondialdehyde; Mitomycin; Models, Animal; Oxidative Stress; Reactive Oxygen Species; Recombinant Proteins; Time Factors; Vero Cells | 2013 |
Role of recombinant human erythropoietin against mitomycin C-induced cardiac, hepatic and renal dysfunction in Wistar rats.
Topics: Animals; Antibiotics, Antineoplastic; Cardiotoxicity; Chemical and Drug Induced Liver Injury; Drug Administration Schedule; Erythropoietin; Heart Failure; Kidney Function Tests; Liver Function Tests; Male; Mitomycin; Organ Size; Rats, Wistar; Recombinant Proteins; Renal Insufficiency | 2015 |
Effect of recombinant human erythropoietin on mitomycin C-induced oxidative stress and genotoxicity in rat kidney and heart tissues.
Topics: Alkylating Agents; Animals; Catalase; Comet Assay; DNA Damage; Drug Administration Schedule; Erythropoietin; Glutathione; Heart; Kidney; Lipid Peroxidation; Male; Mitomycin; Mutagenicity Tests; Myocardium; Oxidative Stress; Protein Carbonylation; Rats | 2016 |
Dosage time affects alkylating agents induced micronuclei in mouse peripheral blood reticulocytes through the function of erythropoietin.
Topics: Administration, Metronomic; Alkylating Agents; Animals; Apoptosis; bcl-X Protein; Bone Marrow Cells; Cell Nucleolus; Circadian Rhythm; Cyclophosphamide; Darkness; DNA Damage; Erythropoietin; Ethyl Methanesulfonate; Light; Male; Methylnitrosourea; Mice, Inbred C3H; Mitomycin; Reticulocytes; Time; Vincristine | 2019 |